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The greatest proportion of foot-and-mouth disease (FMD) clinical research has been 
dedicated to elucidating pathogenesis and enhancing vaccine protection in cattle with 
less efforts invested in studies specific to pigs. However, accumulated evidence from 
FMD outbreaks and experimental investigations suggest that critical components of 
FMD pathogenesis, immunology, and vaccinology cannot be extrapolated from investi-
gations performed in cattle to explain or to predict outcomes of infection or vaccination 
in pigs. Furthermore, it has been shown that failure to account for these differences may 
have substantial consequences when FMD outbreaks occur in areas with dense pig 
populations. Recent experimental studies have confirmed some aspects of conventional 
 wisdom by demonstrating that pigs are more susceptible to FMD virus (FMDV) infection 
via exposure of the upper gastrointestinal tract (oropharynx) than through inhalation 
of virus. The infection spreads rapidly within groups of pigs that are housed together, 
although efficiency of transmission may vary depending on virus strain and exposure 
intensity. Multiple investigations have demonstrated that physical separation of pigs is 
sufficient to prevent virus transmission under experimental conditions. Detailed patho-
genesis studies have recently demonstrated that specialized epithelium within porcine 
oropharyngeal tonsils constitute the primary infection sites following simulated natural 
virus exposure. Furthermore, epithelium of the tonsil of the soft palate supports substan-
tial virus replication during the clinical phase of infection, thus providing large amounts of 
virus that can be shed into the environment. Due to massive amplification and shedding 
of virus, acutely infected pigs constitute a considerable source of contagion. FMDV 
infection results in modulation of several components of the host immune response. 
The infection is ultimately cleared in association with a strong humoral response and, in 
contrast to ruminants, there is no subclinical persistence of FMDV in pigs. The aim of this 
review is to provide an overview of knowledge gained from experimental investigations 
of FMD pathogenesis, transmission, and host response in pigs. Details of the temporo- 
anatomic progression of infection are discussed in relation to specific pathogenesis 
events and the likelihood of transmission. Additionally, relevant aspects of the host 
immune response are discussed within contexts of conventional and novel intervention 
strategies of  vaccination and immunomodulation.
Keywords: foot-and-mouth disease, foot-and-mouth disease virus, pigs, pathogenesis, host response, virus 
diseases, virology
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ReLevANCe
Foot-and-mouth disease (FMD) is recognized as one of the most 
contagious and economically important diseases of domestic live-
stock. The etiological agent, FMD virus (FMDV), an aphthovirus 
of the Picornaviridae family, is capable of infecting a multitude 
of cloven-hoofed animal species including both ruminants and 
suids (1, 2). Although domestic cattle are often prioritized with 
regards to FMD prevention and strategic countermeasures, it is 
important to recognize that pigs constitute a substantial propor-
tion of agricultural production in large areas of the world. Even 
though cattle and pigs may be similarly susceptible to FMDV 
infection under most circumstances, there are critical differences 
in FMD pathogenesis and infection dynamics that emphasize the 
importance of species-specific experimental investigations and 
adaptation of countermeasure policies. Important distinctions 
between cattle and pigs in FMD pathogenesis events include vari-
ations in permissiveness to infection by different routes of virus 
exposure and thereby differences in the most likely mechanisms 
of virus transmission between animals. Furthermore, variations 
in the quantities of virus shed by aerogenous routes, as well as the 
capability of long-term persistence of infectious virus in tissues of 
ruminants, but not pigs, indicate important differences pertain-
ing to risk assessments and practical management of infected or 
convalescent animals.
It is well known that the clinical severity of FMD may vary 
greatly depending both on the virus strain and the affected host 
species (1, 2). Acute clinical FMD has been reported to be more 
severe in pigs compared to ruminant species (1). Contrastingly, 
pigs are more efficient in complete clearance of the infection, and 
there is no subclinical “FMDV carrier state” in suids (3). It has 
also been widely accepted that while pigs are capable of generat-
ing large amounts of aerosolized virus, they are less susceptible to 
airborne infection compared to ruminants (4, 5). Demonstrated 
variability in host range of certain FMDV strains that are signifi-
cantly attenuated in cattle, yet virulent in pigs provides additional 
evidence of the existence of host-specific differences in the 
molecular pathways of FMDV infection (6–9). Specifically, it was 
confirmed that a mutation within the FMDV 3A coding region 
was the determinant for the strictly porcinophilic phenotype of 
the serotype O FMDV that caused an outbreak in Taiwan in 1997 
(8, 10).
A large proportion of experimental studies investigating 
FMDV pathogenesis and vaccinology have been performed in 
cattle. Furthermore, the guidelines for FMDV vaccine production 
published by the World Organization for Animal Health (OIE) 
only define procedures for efficacy testing in cattle (11). In many 
regions, it is common practice to vaccinate only cattle, but not 
pigs, based on the assumption that this practice may be sufficient 
to prevent dissemination of a potential outbreak. This premise 
may be misguided if extrapolated to regions with intensive 
pig production or substantial quantities of wild suids. Several 
experimental studies have demonstrated difficulty in achieving 
sufficient protection against clinical FMD in pigs by vaccination, 
especially when the virus challenge consisted of direct exposure 
to clinically infected pigs (12–15). Additionally, recent experi-
ences from South Korea have shown that high quality FMDV 
vaccines with confirmed efficacy in cattle may fail to elicit suf-
ficient levels of immunity (based on serum neutralization testing) 
when administered to pigs in commercial production settings 
(16). These distinct, porcinocentric scenarios may be explained 
by species-specific differences in susceptibility to the virus or by 
differences in the host response to vaccination. Regardless of the 
causality, the documented variations between cattle and pigs in 
outcomes of both vaccination and infection suggest that FMD 
control policies may, justifiably, be based on species-specific 
data and should be adapted to account for the composition of 
the animal population in any given region. Such differences are 
also highly relevant for disease modeling, wherein it is critical to 
account for species-specific aspects of FMDV infection dynamics 
and transmission in order to precisely model distinct scenarios.
FMD iN PiGS
Routes of infection
Early experimental studies performed by Terpstra (17) concluded 
that pigs were highly susceptible to FMDV via artificial aerosol 
exposure, while a 1000-fold higher inoculation dose was required 
to achieve successful infection by virus instillation in the oral cav-
ity. This was subsequently contradicted in works by Alexandersen 
and Donaldson which demonstrated that pigs were largely 
resistant to FMDV infection by inhalation of naturally produced 
aerosols (4, 5). Additionally, more recent investigations have con-
firmed that the porcine upper respiratory tract (nasopharynx) is 
less permissive to inoculation by direct deposition of virus when 
compared to the upper gastrointestinal tract (oropharynx) (18, 
19). Infection via the oral route is likely mediated by virus entry 
through the mucosal surfaces of the oropharyngeal tonsils rather 
than trough the lower gastrointestinal tract. This is supported by 
demonstrated tropism of tonsillar epithelium to primary FMDV 
infection (20) as well as the instability of FMDV at low pH (21, 
22), which likely leads to dissociation of virus particles that reach 
the stomach. The predilection for virus entry via the porcine 
upper gastrointestinal tract is in direct contrast to primary FMDV 
infection of cattle, which has been demonstrated to occur in the 
upper respiratory tract (23–26). However, despite this apparent 
discrepancy in anatomic location, there are striking similarities 
in microanatomic characteristics of the epithelium that supports 
primary FMDV replication in both cattle and pigs (19, 23, 25). 
Specifically, in both species, primary infection occurs at distinct 
regions of epithelium overlaying mucosa-associated lymphoid 
tissue (MALT). In these regions (so-called reticular- or follicle-
associated epithelium), the epithelium is intimately associated 
with the subjacent lymphoid follicles, the basement membrane is 
discontinuous, and there are abundant intraepithelial (transmi-
grating and resident) leukocytes.
The relative resistance of pigs to aerogenous FMDV infection 
has been further corroborated by several experimental studies, 
which have shown that physical separation of pigs is sufficient 
to prevent transmission of virus under experimental conditions 
(27–29). Contrastingly, direct contact exposure leads to rapid 
transmission of infection within groups of pigs that are housed 
together. Furthermore, it has been demonstrated that this system 
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of virus exposure is often sufficient to overcome vaccine protec-
tion (15) even though vaccination may reduce shedding of virus 
and thereby lower the transmission rate (12, 14). The efficiency 
of transmission of FMDV under experimental conditions varies 
between different strains of FMDV (30, 31). Additionally, exter-
nal factors, such as housing density, the intensity of interactions 
between animals, and the duration of exposure, will directly 
influence the outcome of experimental transmission studies (30, 
32, 33). Even though these findings strongly suggest that direct 
physical contact between pigs facilitates FMDV transmission, 
the specific route of virus entry during contact exposure has 
not been completely identified. The susceptibility of the porcine 
oropharyngeal mucosa to FMDV infection would support 
virus transmission via the oral route, e.g., from salivation and 
subsequent ingestion of shed virus during communal feeding. 
However, direct entry of virus through skin abrasions and punc-
tures derived from biting or oral entry mediated through direct 
contact to exposed vesicular lesions on donor animals may also 
constitute likely transmission routes.
There are many options for challenge systems for FMD 
experimentation in pigs, which reflect the differences described 
above. FMDV infection in pigs is often achieved by intraepi-
thelial injection of the heel bulb (27, 34–39). This technique is 
convenient for vaccine studies, as the pedal epithelium is highly 
permissive to FMDV infection, leading to substantial amplifica-
tion of the injected virus at the inoculation site and consistently 
rapid progression of generalized FMD in susceptible animals. 
Despite the convenience and consistency of injection-based 
inoculation techniques, these systems are less appropriate for 
studies of disease pathogenesis as they are based on an artificial 
route of virus entry that bypasses the natural barrier of the 
mucosal immune system. As mentioned above, direct contact 
exposure to infected animals is highly efficient in generating 
infection in susceptible animals. However, critical factors, such 
as the dose and timing of virus challenge, are difficult to control 
in contact-based systems, which may lead to inconsistencies 
across studies or misinterpretations of experimental outcomes. 
Recent studies have demonstrated that controlled exposure of 
the porcine upper gastrointestinal tract by deposition of virus 
inoculum in the oropharynx of sedated pigs is highly efficient in 
generating consistent and synchronous clinical FMD and may 
thus be considered a valid alternative to the more traditional 
injection-based challenge systems (18–20).
Temporo-Anatomic Progression 
of infection
Primary Infection (Pre-Viremia)
Relatively few experimental studies have been dedicated to 
investigation of the progression of FMDV infection in porcine 
tissues following natural or simulated natural virus exposure (17, 
20, 34, 36, 40). There is general agreement across these investiga-
tions that epithelial tissues of the oropharynx constitute the main 
sites of virus replication during early infection, whereas abundant 
amplification of virus occurs in vesicular lesions at secondary 
(peripheral) replication sites (Figure 1). However, there are slight 
variations among published works regarding the interpretation 
of the precise events that constitute the initial phase of FMDV 
infection in pigs.
A recent investigation demonstrated specific predilection 
of primary FMDV infection to porcine paraepiglottic tonsils 
(Figure 2A). This was concluded based on consistent detection 
of FMDV RNA and infectious virus by qRT-PCR and virus isola-
tion (VI), respectively, prior to the development of viremia and 
generalization of infection. Additionally, FMDV structural and 
non-structural viral proteins were localized to crypt epithelium 
of this specific tonsil by immunomicroscopy at 6–24  h post 
intraoropharyngeal inoculation (20). Early detection of FMDV 
RNA and infectious virus was more variable in the tonsil of the 
soft palate, lingual tonsil, and the dorsal soft palate, suggesting 
that these sites may also be potential sites of primary infection. 
A similar investigation performed by Murphy et al. (34) reported 
detection of FMDV RNA in tonsils, submandibular lymph nodes, 
spleen, liver, tongue, skin, and pharynx, prior to the detection of 
viremia. However, the earliest time point for tissue collection in 
this study was 24 h post contact exposure, which may account for 
the somewhat wider distribution of viral genome. Additionally, in 
this study, localization of viral replication was not confirmed by VI 
or microscopy. Similarly, an earlier investigation by Alexandersen 
et al. (36) concluded that the highest quantities of FMDV RNA 
during pre-clinical infection of contact exposed pigs were found 
in the dorsal soft palate and tonsil (24–48  h post exposure). 
Noteworthy for these latter two investigations is that the term 
“tonsil” is not further defined anatomically but may be assumed to 
represent the tonsil of the soft palate. However, there are multiple 
distinct tonsils in the porcine oropharynx, including the tonsil of 
the soft palate, lingual tonsil, and paraepiglottic tonsils (41).
An earlier study by Brown et al. (40) described an investiga-
tion of tissue distribution of FMDV RNA by in situ hybridization 
(ISH) in pigs infected by intraepithelial injection, as well as 
morphological characterization of microscopic lesions associated 
with the detection of viral genome. This study described wide-
spread dissemination of FMDV genome in the epidermis from 
24 to 96 hours post infection (hpi), at sites with or without visible 
FMDV-associated lesions (40). The study does not include deter-
mination of the onset of viremia and systemic dissemination of 
virus in relation to the time points for tissue collection. However, 
it is mentioned that pigs euthanized at 24 hpi, corresponding to 
the earliest time point investigated, were clinically depressed with 
marked vesicles at the epithelial inoculation sites on the snout and 
lips. The somewhat different findings between these published 
studies highlights the differences in experimental outcomes per-
taining to experimental design, e.g., inoculation/exposure routes 
and time points included in the investigation, as well as methods 
used for virus detection. It is clear that detection of virus genome 
by qRT-PCR or ISH may lead to different outputs compared to 
VI or detection of antigen by immunomicroscopy. Combining 
multiple techniques incurs additional cost and time investment, 
but ultimately provides a more detailed and substantiated experi-
mental output.
Viremia and Clinical Disease
In all in vivo studies, the onset of viremia is a critical milestone in 
FMD pathogenesis, as it accompanies a surge in contagion and 
FiGURe 1 | Schematic illustration of virus distribution in tissues during distinct phases of FMD in pigs. (A) During the pre-viremic phase of infection, 
primary virus replication is localized to epithelium of oropharyngeal tonsils. (B) During the clinical phase of infection, FMDV can be recovered from essentially every 
tissue or organ sampled due to high titers of virus in blood. Virus replication in oropharyngeal tonsil epithelium continues, while substantial amplification of FMDV 
occurs in vesicular lesions on the feet, snout, and in the oral cavity. (C) After resolution of viremia and clinical disease, FMDV genome and antigen can be recovered 
from lymph nodes that drain lesion sites for up to 2 months. However, there is no persistence of infectious virus.
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predicts the impending clinical syndrome. In pigs, viremia may 
be detected as early as 24 h after natural or artificial virus expo-
sure, and it is associated with a substantial increase in shedding 
of infectious virus via the oropharyngeal route (3, 20, 30, 42). The 
onset of clinical FMD, which usually occurs approximately 24 h 
after detection of viremia, is characterized by fever, loss of appe-
tite, and the appearance of vesicular lesions on feet, snout, and 
within the oral cavity (20, 30, 34). The initial phase of infection, 
consisting of the progression from primary, pre-viremic, infec-
tion to viremia and clinical disease may be prolonged following 
exposure to an FMDV strain of reduced virulence, or if exposure 
conditions are less stringent (e.g., suboptimal exposure route, low 
challenge dose, or time-limited exposure) (19, 27, 30, 33, 43).
During clinical FMD, the highest quantities of infectious virus 
are found in vesicular lesions in cornified epithelium of the feet 
(heel bulbs and coronary bands), on the snout and on the dorsal 
surface of the tongue (20, 34, 36, 40). It has recently been dem-
onstrated that during clinical disease abundant virus replication 
occurs in epithelial crypts of the tonsil of the soft palate, and that 
microscopic vesicular lesions containing large quantities of viral 
protein can be detected at this site (Figures 2B,C) (20). During 
peak viremia, FMDV RNA and infectious virus can be recovered 
FiGURe 2 | Development of microvesicles within oropharyngeal tonsil 
epithelium during early infection. (A) Earliest detection of infection occurs 
within paraepiglottic tonsil at 24 h post intraoropharyngeal inoculation. FMDV 
antigen (red) in clusters of infected cytokeratin-positive (green) epithelial cells 
in superficial layers of crypt epithelium. (B) At 48 h post intraoropharyngeal 
inoculation, a single microvesicle is present within the tonsil of the soft palate. 
Focus of FMDV-infected (red) epithelial cells expanding through deeper layers 
of epithelium (green). (C) At 78 h post intraoropharyngeal inoculation, three 
distinct microvesicles are present within crypt epithelium of the tonsil of the 
soft palate. Sloughed FMDV VP1/cytokeratin double positive cells are present 
in vesicle lumen. 10× magnification.
(Continued)
FiGURe 2 | Continued
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from essentially any tissue sampled (Figure 1), but such detec-
tion represents intravascular, viremic FMDV rather than regional 
replication (20).
It is well established that clinically infected pigs release infec-
tious FMDV in exhaled air at quantities substantially greater than 
cattle (43–46). However, the anatomic source of exhaled virus 
remains incompletely elucidated. Donaldson and Ferris (47) 
used an approach of direct air sampling from intact or intubated 
pigs to evaluate the sources of exhaled virus during different 
phases of FMD. This demonstrated that infectious FMDV was 
primarily recovered from the upper respiratory tract during early 
infection, but that both upper and lower segments of the respira-
tory tract contributed to exhaled virus during the clinical phase 
of FMD (47). Unfortunately, there was no collection or analysis 
of tissue samples in this study, and more detailed conclusions 
 regarding the anatomic sites of released virus are therefore lack-
ing. With the exception of Terpstra (17), tissue-based pathogen-
esis studies have failed to demonstrate substantial amplification 
of FMDV in porcine lungs (20, 34, 36).
The tonsil of the soft palate is the only tissue in the respiratory 
or gastrointestinal tract that has been shown to support substan-
tial levels of FMDV replication (20, 36), and it is therefore the best 
candidate as the source of aerosolized FMDV derived from pigs. 
This tonsil is located at the dorsal boundary of the oropharynx 
and is therefore not within the direct route of exhaled air pass-
ing from the lungs through the nasopharynx and nasal cavity. 
However, the tonsil is anatomically continuous with the dorsal 
soft palate, and therefore FMDV originating from the tonsil may 
be aerosolized in the nasopharynx. Additionally, exhalation of 
air through the oropharynx and mouth, as would occur during 
vocalization, would pass directly across the surface of the tonsil 
of the soft palate and facilitate direct aerosolization. Another 
potential source of airborne virus is secondary resuspension of 
virus that has been shed into the environment in secretions and 
sloughed vesicles. However, this would not provide an explana-
tion for the apparently higher quantities of aerogenous virus 
produced by pigs compared to cattle.
Despite relative resistance to FMDV infection via aerog-
enous exposure (4, 5), clinically infected pigs are a potential 
source of infection for exposed ruminants due to release of large 
amounts of aerosolized virus (44). Furthermore, the extent 
of virus dissemination in porcine tissues during viremia is 
noteworthy in that pigs and pork harvested during the viremic 
phase of disease contain massive loads of infectious FMDV. 
Thus, FMDV-infected pigs constitute a considerable source of 
contagion during the clinical phase of disease, and movement 
of live pigs or associated products can have substantial impact 
on disease spread. These aspects of FMD pathogenesis are of 
FiGURe 3 | Progression of foot lesions in pig infected with FMDv A24 Cruzeiro at 2 (A) and 24 (B) days after intraoropharyngeal inoculation.  
(A) Vesicular lesion on solar aspect of hind foot at 2 dpi. Blanching (white) epithelium (delineated within arrows) extends across both heel bulbs and interdigital skin 
with clear demarcation from normal skin. (B) The same animal at 24 dpi. Proliferative dyskeratotic scar tissue has replaced sloughed epithelium.
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critical importance for the establishment of efficient measures 
to control outbreaks. Stringent restrictions on movements 
of animals and animal products, as well as depopulation of 
infected premises are generally required in order to control 
dissemination of the disease, regardless of whether emergency 
vaccination is applied.
Clearance of Infection
The clinical phase of FMD subsides within approximately 
7–14 days post infection (dpi). In the absence of complications 
due to secondary bacterial infections, adult pigs generally recover 
from FMDV infection, although severe foot lesions may cause 
enduring lameness and debilitation (Figure 3).
FMDV-neutralizing antibodies can be measured in serum 
of the infected pigs from approximately 4–7 dpi (39, 48). This is 
followed by a subsequent clearance of infectious virus from blood 
within approximately 7–14 dpi (3, 49). A single publication by 
Mezencio et al. (50) concluded that it was possible to detect FMDV 
RNA in porcine sera as late as 300 dpi. However, this finding has 
not been repeated or confirmed in any subsequent investigations. 
Consistent shedding of FMDV RNA can be detected in oral and 
nasal secretions for up to 14  dpi (3, 49), with some variation 
across different virus strains. It is likely that the infectiousness of 
shed virus and thereby contagion associated with pigs recovering 
from infection is substantially reduced concurrent with increas-
ing titers of neutralizing antibodies in secretions. Nonetheless, 
despite a large number of published FMDV contact transmission 
studies, there is no detailed experimental investigation that has 
precisely documented the duration of infectiousness of FMDV-
infected pigs.
In contrast to ruminant species, pigs that survive FMDV 
infection efficiently clear infectious virus from all tissues after 
resolution of the clinical disease (3). A study by Rodriguez-Calvo 
et al. (49) demonstrated that infectious serotype C FMDV could 
be recovered from porcine tonsils as late as 17 dpi, postulating 
existence of a putative FMDV carrier state in pigs. A subsequent 
investigation, using five different strains of FMDV, demonstrated 
that it was not possible to recover infectious FMDV from any 
porcine tissues harvested beyond 28  dpi, corresponding to the 
commonly acknowledged threshold for FMDV persistence (3). 
However, the same investigation showed that (non-infectious) 
FMDV RNA could be detected within porcine lymphoid tissue 
for up to 60  dpi, with highest detection prevalence and most 
abundant RNA quantities found in the popliteal lymph node 
that drains the hind feet (Figure  1). Concurrent detection of 
FMDV structural protein and absence of non-structural protein 
in popliteal lymph nodes by immunomicroscopy supported 
the conclusion that viral degradation products may persist 
in lymphoid organs beyond clearance of infectious virus (3). 
Detection of FMDV RNA in lymph nodes harvested from both 
domestic and feral pigs after resolution of clinical disease has 
been demonstrated in several studies (51–53). However, there is 
no convincing report documenting isolation of infectious FMDV 
from porcine tissues beyond 17 dpi.
FMDv Myocarditis in Pigs
Although FMD-related mortality among adult pigs is generally 
low, mortality rates may be higher in juvenile animals (1), and 
there are often reports of sporadic deaths occurring during 
experimental studies (6, 19, 31, 54, 55). FMD-related deaths are 
often attributed to acute viral myocarditis, even in cases when 
the precise cause of death has not been definitively determined. 
However, it is well established that acute FMDV infection may 
cause infection of the myocardium, leading to heart failure and 
FiGURe 4 | Gross, histological, and immunomicroscopic characterization of FMDv myocarditis. (A) Gross image of porcine heart with confirmed 
FMDV-associated myocarditis. Multifocal pallor on the surface of both right and left ventricles (arrows). (B,C) Right ventricle of pig found dead at 5 days post 
infection with FMDV A24 Cruzeiro. Interstitial edema and mixed mononuclear infiltrates consisting of lymphocytes, large macrophage-like cells, and scarce 
neutrophils. Myocyte necrosis and fragmentation (arrows). Hematoxylin and eosin (B) 4× magnification, (C) 20× magnification. (D) Immunohistochemical staining 
demonstrating localization of FMDV within cardiomyocytes. Anti-FMDV capsid monoclonal antibody (red). Micropolymer alkaline phosphatase. Gill’s hematoxylin 
counterstain. 20× Magnification. Gross image (A) was edited to reduce artifactual glare from flash; lesion areas were not modified.
7
Stenfeldt et al. FMD Pathogenesis in Pigs
Frontiers in Veterinary Science | www.frontiersin.org May 2016 | Volume 3 | Article 41
sudden death (56–58). The gross pathological findings associ-
ated with FMDV-induced myocarditis may range from complete 
absence of visible lesions to distinct areas of pallor on the cardiac 
surface that extend into subjacent myocardium (Figure  4A). 
Effusion in thoracic and/or abdominal cavities may occur in 
subacute or chronic cases indicating congestive heart failure, but 
are often absent in acute, rapidly progressing cases. The terms 
“tiger stripes” or “tiger heart” are commonly used to describe 
gross pathological changes associated with FMDV myocarditis. 
It is our opinion that these are inappropriate and often confus-
ing descriptions as the myocardial pallor induced by FMDV 
myocarditis rarely assumes a striped pattern. In contrast, stripe-
like pale coloration of the myocardial surface is often found as 
part of normal anatomy associated with superficial vessels and 
epicardial fat.
Histological findings suggestive of FMDV-induced myo-
carditis may be predominantly acute and necrotizing or 
subacute–chronic with various hallmarks of inflammation 
(Figures  4B,C). Generally, necrosis and inflammation coexist 
in every lesion with continuum of severity. Inflammation typi-
cally includes lymphohistiocytic infiltration and edema, whereas 
 cardiomyocyte degeneration and necrosis may occur as individual 
cells, small clusters, or may be regionally extensive (Figure 4C) 
(58). Regions of architectural disruption may have evidence of 
viral replication including presence of viral antigens and nucleic 
acids detectable by immunomicroscopy and in situ hybridization, 
respectively (Figure 4D).
Viral loads in the myocardium are massive, often approaching 
levels otherwise only found in vesicular lesions (58). The preva-
lence of FMDV myocarditis varies between different strains of 
FMDV as well as the age of the infected host (2). Interestingly, 
despite extensive investigation, we have not found evidence of 
FMDV replication in myocardium of any infected pigs that did 
not display clinical signs of heart failure.
8Stenfeldt et al. FMD Pathogenesis in Pigs
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Since FMDV RNA and infectious virus can be recovered 
from essentially any tissue harvested during the viremic phase of 
infection, isolation of FMDV from the heart of a pig with FMD 
is not sufficient for a diagnosis of FMDV myocarditis. A tenta-
tive diagnosis of myocarditis may be based on clinical history 
of unexpected death in an animal confirmed to be infected with 
FMD combined with gross findings of (multi)focal mycocardial 
pallor (Figure 4A). Viral loads in myocardium, which are higher 
than those detected in serum, provide further support. But, 
confirmation of FMDV myocarditis requires histopathological 
identification of lesions combined with immunohistochemical 
confirmation of presence of FMDV. Additionally, it is noteworthy 
that identical clinical and histopathological findings have been 
documented following infection of pigs with encephalomyocardi-
tis virus (EMCV) (59, 60), a related Picornavirus with worldwide 
distribution (61).
HOST ReSPONSe TO FMDv iN PiGS
FMD virus has been demonstrated to modulate the host immune 
response via several mechanisms. Thus, understanding host/
pathogen interactions and elucidating the contributions of innate 
versus adaptive immune responses have become a central topic in 
FMDV research. Although the host response to FMDV infection 
is incompletely elucidated, in recent years several studies in swine 
and cattle have been published, some of them with controversial 
results. These differences directly reflect the existence of species-
specific variations in both systemic and cellular responses to 
infection (62) that ultimately justifies continued investigation in 
both suids and ruminants.
Cellular and Humoral immune Response
During the early phase of viral infections, interactions between 
pathogens and cellular components of the innate immune 
response, such as natural killer (NK) cells, dendritic cells (DCs), 
and macrophages, define the cellular and humoral adaptive 
immune response that is believed to ultimately clear the infection. 
During FMDV replication in pigs, the virus may come in contact 
with antigen-presenting cells (APCs), either as a result of lytic 
infection of epithelial cells and subsequent phagocytosis of dam-
aged tissue (63) or by direct infection of immune cells through an 
antibody-dependent internalization process [macrophages (64, 
65) or DCs (66, 67)]. Although the interactions between FMDV 
and APCs have been shown to be abortive and no virions are 
produced (63, 67), there are functional consequences that affect 
the host response. During acute infection, the virus stimulates 
DCs to produce interleukin (IL)-10, thus directing the adaptive 
immune response toward a stronger humoral rather than a 
T-cell-mediated response (67). FMDV also blocks the ability of 
porcine DCs to differentiate into mature conventional DCs (67) 
and impairs the response to stimulation by TLR ligands (68).
A distinct subset of DCs; plasmocytoid DCs (pDCs), are 
susceptible to FMDV infection in  vitro (66). pDCs internalize 
immunoglobulin-bound FMDV immune complexes via FcγRII 
surface receptors, and uptake of these complexes results in abor-
tive virus replication (66). Similarly, studies in pigs have shown 
that these cells are directly affected by FMDV, as the infection 
leads to depletion of pDCs in peripheral blood, and the remaining 
pDCs are less capable of producing interferon (IFN)-α in response 
to ex vivo stimulation by TLR ligands or FMDV (69). Porcine 
Langerhan cells (LCs), identified as a langerin-expressing subset 
of DCs found in the epidermis (70), are also affected by FMDV 
infection (68, 71). Although these cells constitutively express type 
I IFN, in vitro studies have demonstrated that FMDV is able to 
attach to, and become internalized by LCs; however, there is no 
evidence of internalization leading to replication of viral RNA or 
production of viral proteins (71). Furthermore, LCs from FMDV-
infected pigs produced less IFN-α after ex vivo stimulation, 
although the cells’ ability to present antigen was retained (68).
Natural killer cells also play a critical role during the initial 
host response to pathogens. Although in  vitro stimulation of 
porcine NK cells using pro-inflammatory cytokines induces 
lysis of FMDV-infected cells and increased expression of IFN-γ 
(72), in vivo studies have demonstrated that NK cells from swine 
infected with FMDV have a reduced capacity to lyse target cells 
and secrete IFN-γ (72). NK cell dysfunction during the viremic 
phase of acute infection suggests that FMDV can effectively block 
NK function, thereby evading the host’s immune system and 
promoting virus replication and dissemination within the host.
Another mechanism whereby FMDV may evade the porcine 
cellular immune response is the induction of severe lymphopenia 
and lymphoid depletion during peak viremia. The lymphopenia 
is accompanied by a long-lasting suppression of T-cell function, 
as T-cells have been shown to respond poorly to mitogen stimulus 
even after the lymphopenia is resolved (73, 74). However, the 
mechanisms by which the virus induces this immunosuppression 
are not completely understood. Lymphocyte depletion and T-cell 
dysfunction may be caused by viral replication in lymphocytes 
as has been described during FMDV serotype C infection in 
swine (73), as well as in in vitro experiments investigating FMDV 
infection of bovine peripheral blood mononuclear cells (PBMCs) 
(75). However, subsequent studies concluded that active infection 
of lymphocytes by FMDV could not be demonstrated when pigs 
were infected with other FMDV serotypes (69, 74). Furthermore, 
these investigations concluded that FMDV infection was not 
associated with cell death, suggesting that lymphopenia during 
FMDV infection might not be related to virus-mediated kill-
ing. Additionally, it cannot be ruled out that FMDV-associated 
lymphopenia may represent a shift of circulating lymphocytes 
from circulating pool to marginating and tissue-residing pools. 
An additional mechanism that may contribute to the diminished 
T cell response during FMDV infection could be related to the 
elevated amounts of IL-10 produced by conventional DCs that, as 
mentioned above, has been reported to have immunosuppressive 
functions in vivo for FMDV (67) and for other viruses (76).
Despite the apparent inhibitory actions of FMDV on the 
cellular host response during early infection, pigs are capable 
of mounting a substantial humoral response within few days 
of infection, and there is no documentation of any long-term 
negative effects on the immune system in pigs that survive FMDV 
infection. In fact, the high levels of IL-10 during acute infection 
may skew the adaptive immune response toward a stronger 
humoral rather than a T-cell-mediated cellular response. The 
serological response of naive pigs to FMDV infection consists of 
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a rapid surge of anti-FMDV IgM that peaks at 7 dpi and subse-
quently declines to baseline levels by approximately 4 weeks after 
infection (39). The IgM response is followed by a sustained anti-
FMDV IgG response, which remains at high titers beyond 28 days 
(39). High titers of neutralizing antibodies can be detected as 
early as 4–7 days after infection, and unpublished results from 
our laboratory have confirmed that neutralizing antibody titers 
remained at high levels as late as 100  days after infection with 
FMDV A24 Cruzeiro. To the best of our knowledge, there is no 
published documentation of the duration of immunity following 
FMDV infection in pigs.
Systemic Antiviral Host Response
Type I, II, and III IFNs, including IFN-α, -β, -γ, and -λ, are 
critical components of the innate host response to viral infec-
tion. Induction of IFN pathways involve initial recognition of 
pathogen-associated molecular patterns (PAMPs) by cellular 
pattern-recognizing receptors (PRRs), such as the family of toll-
like receptors (TLRs) and cytosolic sensors, eventually leading to 
the activation of interferon-stimulated genes (ISGs) and produc-
tion of a variety host proteins with antiviral  functions (77–82).
FMD virus has been shown to partially counteract the innate 
immune response in vitro by blocking the expression of IFN (83, 
84). Similarly, in vivo in pigs, it has been shown that during acute 
infection FMDV suppresses IFN-α production by skin, myeloid, 
and plasmacytoid DCs (68, 69, 74). However, it has also been 
reported that FMDV infection induces a systemic IFN response, 
which coincides with the onset of viremia (69).
Although the extent of endogenous IFN response in FMDV-
infected pigs is incompletely understood, it has been thoroughly 
documented that FMDV replication in pigs is highly sensitive to 
the exogenous administration of type I, II, and III IFNs delivered 
using recombinant vector constructs (83, 85–88). Specifically, 
pigs pretreated with human adenovirus serotype 5 (Ad5) vectors 
expressing either porcine IFN-α (Ad5–poIFN-α), porcine IFN-β 
(Ad5–poIFN-β), porcine IFN-γ (Ad5–poIFN-γ), or porcine 
 IFN-λ (Ad5–poIFN-λ) were efficiently protected against chal-
lenge with different FMDV serotypes at 1 day after IFN delivery 
(37, 88–91) and IFN-induced protection has been demonstrated 
to last approximately 3–5 days (90). Interestingly, combination of 
type I and type II IFN results in synergistic anti-FMDV activity 
in vivo; swine inoculated with a combination of Ad5–poIFN-α 
and Ad5–poIFN-γ, at doses that alone do not protect against 
FMDV, are completely protected against clinical disease and do 
not develop viremia (88). More recently, a similar approach using 
an Ad5 that expressed porcine IFN-α and IFN-γ bicistronically 
also showed an enhancement of the antiviral activity as compared 
to Ad5 constructs that only expressed either IFN alone (92). 
Studies aimed at elucidating the mechanisms by which IFN pro-
tects swine against FMD have demonstrated that protection of 
swine inoculated with Ad5–poIFN-α correlated with recruitment 
of skin DCs (38), which showed a partial maturation phenotype 
with increased expression of CD80/86 and decreased phagocytic 
activity (93).
Administration of Ad5–IFN, type I, II, or III to cattle or 
pigs leads to induction of numerous genes in association with 
protection against FMDV (38, 88, 93). However, by directly 
administering IFN constructs, the natural pathways of interac-
tion of unique viral molecules (or PAMPs) with specific PRRs 
present in host cells are bypassed. Therefore, to induce a broader, 
enhanced, and prolonged antiviral response, treatment of 
animals with various PAMPs could potentially result in a posi-
tive feedback induction of additional IFN production (94, 95). 
Recently, two different strategies have successfully exploited this 
concept in pigs: (i) the use of double stranded RNA, poly IC, in 
combination with IFN treatment (96) and (ii) expression of a 
constitutively active transcription factor, IRF7/3 (5D) fusion 
protein delivered with the Ad5 vector platform (97).
The value of enhanced understanding of IFN and ISG effects 
upon FMDV replication in pigs derives from the potential to 
develop combined-delivery products containing FMDV vaccines 
and select immunomodulatory constructs. Such products could 
provide rapid onset and broad protection that could prevent pri-
mary virus infection prior to the development of vaccine-induced 
antibodies. Additionally, enhancement of specific pathways of the 
innate host response may also serve to strengthen the adaptive 
immune response, ultimately leading to an overall improved 
vaccine response.
CONCLUDiNG ReMARKS
To summarize the consensus interpretation of typical FMD 
pathogenesis in pigs, the majority of experimental investigations 
suggest that primary FMDV replication during pre-viremic 
infection occurs in the oropharynx. More detailed investigations 
have identified epithelial crypts of oropharyngeal tonsils as 
preferred site of primary infection. Oropharyngeal shedding of 
virus increases substantially concurrent with the development of 
viremia, which occurs approximately 24  h prior to appearance 
of clinical FMD lesions. Abundant quantities of infectious virus 
can be recovered from essentially all tissues harvested during 
peak virema, although virus replication in the oropharynx and in 
vesicular lesions on the feet, snout, and in the mouth constitute 
the most significant sources of contagion during the clinical 
phase of disease. FMDV modulates the host immune response 
and causes severe lymphopenia during acute infection. However, 
there is a strong humoral immune response, and virus is cleared 
from circulation within 2 weeks of infection. FMDV RNA and 
structural antigen may be recovered from lymphoid tissues for 
several weeks after resolution of the clinical disease, but there is 
no evidence of the existence of an FMDV carrier state in pigs. 
These distinct aspects of FMD in pigs should be considered in 
the development and deployment of response policies and in the 
modeling of FMD in pigs.
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